PGEN
Precigen IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.51B
P/E Ratio
—
EPS
$-1.21
Beta
1.07
52W High
$5.47
52W Low
$1.28
50-Day MA
$3.95
200-Day MA
$3.93
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
212.77
PEG Ratio
—
About Precigen Inc
Precigen, Inc. discovers and develops the next generation of cell and gene therapies in the United States. The company is headquartered in Germantown, Maryland.
Fundamentals
| Revenue (TTM) | $31.59M |
| Gross Profit (TTM) | $-11.18M |
| EBITDA | $-86.33M |
| Operating Margin | -25.80% |
| Return on Equity | -1145.00% |
| Return on Assets | -42.10% |
| Revenue/Share (TTM) | $0.10 |
| Book Value | $0.06 |
| Price-to-Book | 74.79 |
| Price-to-Sales (TTM) | 47.84 |
| EV/Revenue | 49.23 |
| EV/EBITDA | -3.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1634.00% |
| Shares Outstanding | $356.51M |
| Float | $189.75M |
| % Insiders | 13.63% |
| % Institutions | 70.97% |
Historical Volatility
HV 10-Day
77.37%
HV 20-Day
63.63%
HV 30-Day
56.87%
HV 60-Day
86.29%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($11.00 target)
1
Strong Buy1
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026